デフォルト表紙
市場調査レポート
商品コード
1574942

医薬品製剤市場：剤形別、適応症別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Drug Formulation Market, By Dosage Form, By Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
医薬品製剤市場：剤形別、適応症別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

レポートハイライト

医薬品製剤市場規模は2023年に1兆7,590億2,343万米ドルとなり、2024年から2032年にかけてCAGR 6.01％で拡大

医薬品製剤市場-市場力学

個別化医療と標的治療に対する需要の高まりが成長を牽引

個別化医療と標的治療に対する需要の高まりが、医薬品製剤市場の成長を牽引しています。個別化医療は、個々の患者のニーズに合わせて治療を調整し、治療成績と効率を向上させる。米国立衛生研究所（NIH）によると、1,800件以上の臨床試験が個別化治療に焦点を当てています。

このシフトは、様々な患者群に合わせた治療を作り出すことの重要性を浮き彫りにしています。教育機関もまた、新しい製剤や治療戦略を研究することで貢献しています。ヘルスケアの進化に伴い、個別化アプローチの重視は拡大し、患者と医薬品製剤業界の双方に利益をもたらす可能性が高いです。

医薬品製剤市場-主な洞察

当社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約6.01%のCAGRで毎年成長すると推定されます。

剤形別では、経口製剤が2023年に最大市場シェアを示すと予測

適応症別では、感染症が2023年の主要タイプでした。

エンドユーザー別では、大手製薬企業が2023年の主要企業でした。

地域別では、北米が2023年の売上高でトップ

医薬品製剤市場-セグメンテーション分析：

世界の医薬品製剤市場は、剤形、適応症、エンドユーザー、地域に基づいてセグメント化されます。

市場は剤形別では、3つに分類される：経口剤、非経口剤、局所剤、吸入剤です。経口剤は最も顕著なセグメントです。このカテゴリーには錠剤やカプセルのような様々な形態が含まれ、その利便性と投与の容易さから広く使用されています。中でも錠剤、特に即時放出型のものは、製造が簡単で保存期間が長いため、高い人気があります。経口剤は、その有効性と快適性から患者にもヘルスケアプロバイダーにも好まれており、市場では圧倒的な選択肢となっています。

市場は適応症別では、2つのカテゴリーに分けられる：感染症、がん、心血管系疾患、糖尿病、呼吸器系疾患、中枢神経系疾患、その他です。最も顕著なセグメントは感染症です。これは、特にCOVID-19パンデミックのような最近の世界の健康危機によって強調された、効果的な治療とワクチンの継続的な必要性によるところが大きいです。ヘルスケアシステムが感染症の予防と治療に注力しているため、抗ウイルス薬や抗生物質に対する需要は依然として高いです。さらに、この分野における新しい治療法の急速な開発が技術革新と投資を促進し、感染症が医薬品製剤の主要な焦点となっています。

医薬品製剤市場-地理的洞察

北米の医薬品製剤市場は非常に重要で、急速に成長しています。米国はこの市場の最大の部分を占めており、多くの製薬会社が新薬を開発しています。これらの企業は、様々な健康問題を治療するための安全で効果的な医薬品製剤の開発に注力しています。技術と研究の進歩は、薬物送達方法の改善に役立っています。カナダもヘルスケア分野の研究と技術革新を支援することで貢献しています。さらに、厳しい規制が製剤の高品質基準を保証しています。全体として、北米は医薬品製剤市場の将来を形作る上で重要な役割を果たしています。

医薬品製剤市場-競合情勢：

医薬品製剤市場は競争が激しく、Pfizer, Johnson & Johnson, and Rocheなどの大手企業が市場をリードしています。これらの企業は、新しく効果的な医薬品を生み出すために研究開発に多額の投資を行っています。Merck & Co. and Bristol-Myers Squibb社も、革新的な治療法に注力する重要な競合企業です。GSKとノバルティスは、強力な製品ポートフォリオと世界な展開で貢献しています。さらに、アッヴィやアムジェンといった企業は、特殊医薬品で知られています。市場は常に進化しており、テクノロジーの進歩やヘルスケアニーズの変化がその原動力となっています。この競合がイノベーションを促進し、患者により良い治療をもたらすのです。

目次

第1章 医薬品製剤市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 医薬品製剤の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 医薬品製剤産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 医薬品製剤市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 医薬品製剤市場情勢

  • 医薬品製剤市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 医薬品製剤市場- 剤形別

  • 概要
    • 剤形別セグメントシェア分析
    • 経口剤
      • タブレット
      • 即効型薬剤
      • 放出調節製剤
      • 噛める
      • 発泡性
      • カプセル
      • ハードゼラチンカプセル
      • ソフトジェルカプセル
      • その他
      • 粉末・顆粒
      • ロゼンジとトローチ
      • グミ
      • その他
    • 非経口製剤
      • 溶液
      • 浮遊物
      • 注射または点滴用の乳剤
      • 注射または点滴用の粉末
      • 注入インプラント用ゲル
    • 局所用製剤
      • ペースト
      • 軟膏とオイル
      • クリーム、ローション、フォーム。
      • ジェル、チンキ剤、粉末
      • スプレーとパッチ
    • 吸入製剤
      • 加圧式定量吸入器
      • ドライパウダー吸入器（DPI）
      • ネブライザー

第8章 医薬品製剤市場- 適応症別

  • 概要
    • 適応症別セグメントシェア分析
    • 感染症
    • がん
    • 心血管疾患
    • 糖尿病
    • 呼吸器疾患
    • 中枢神経系疾患
    • その他

第9章 医薬品製剤市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 大手製薬会社
    • 中小規模の製薬会社
    • バイオテクノロジー企業

第10章 医薬品製剤市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 医薬品製剤業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Pfizer
    • Johnson &Johnson
    • Roche
    • Merck &Co.
    • Bristol-Myers Squibb
    • GSK（GlaxoSmithKline）
    • Novartis
    • AbbVie
    • Sanofi
    • Amgen
    • AstraZeneca
    • Bayer
    • Teva Pharmaceutical Industries
    • Mylan
    • Celgene

第12章 アナリストの全方位展望

目次
Product Code: ANV3941

REPORT HIGHLIGHT

Drug Formulation Market size was valued at USD 1,759,023.43 Million in 2023, expanding at a CAGR of 6.01% from 2024 to 2032.

The drug formulation market involves the development and production of medications in various forms, like tablets, capsules, and injections. It focuses on combining active ingredients with other substances to create effective and safe drugs. This market plays a crucial role in healthcare by ensuring that medicines can deliver the right dosage and work effectively in the body. Companies in this market conduct research to improve existing drugs and develop new ones. The goal is to provide better treatments for various diseases and conditions. Overall, the drug formulation market is essential for advancing medicine and improving patient care.

Drug Formulation Market- Market Dynamics

Rising demand for personalized medicine and targeted therapies drives growth

Rising demand for personalized medicine and targeted therapies is driving growth in the drug formulation market. Personalized medicine tailors' treatments to individual patient needs, improving outcomes and efficiency. According to the National Institutes of Health (NIH), over 1,800 active clinical trials are focusing on personalized therapies.

This shift highlights the importance of creating tailored treatments for various patient groups. Educational institutions also contribute by researching new formulations and treatment strategies. As healthcare evolves, the emphasis on personalized approaches is likely to expand, benefiting both patients and the drug formulation industry.

Drug Formulation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.01% over the forecast period (2024-2032)

Based on Dosage Form segmentation, Oral formulations was predicted to show maximum market share in the year 2023

Based on Indication segmentation, Infectious Diseases was the leading type in 2023

Based on End User segmentation, Big Pharma Companies was the leading type in 2023

Based on Region, North America was the leading revenue generator in 2023

Drug Formulation Market- Segmentation Analysis:

The Global Drug Formulation Market is segmented based on Dosage Form, Indication, End User, and Region.

The market is divided into three categories based on Dosage Form: Oral formulations, Parenteral formulations, Topical formulations, and Inhalation formulations. Oral formulations are the most prominent segment. This category includes various forms like tablets and capsules, which are widely used due to their convenience and ease of administration. Among these, tablets, especially immediate-release ones, are highly popular because they are simple to produce and have a long shelf life. Oral formulations are preferred by both patients and healthcare providers for their effectiveness and comfort, making them the dominant choice in the market.

The market is divided into two categories based on Indication: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, and Others. Infectious diseases represent the most prominent segment. This is largely due to the ongoing need for effective treatments and vaccines, especially highlighted by recent global health crises like the COVID-19 pandemic. The demand for antiviral and antibiotic drugs remains high as healthcare systems focus on preventing and treating infections. Additionally, the rapid development of new therapies in this area drives innovation and investment, making infectious diseases a dominant focus in drug formulation.

Drug Formulation Market- Geographical Insights

The North American drug formulation market is very important and is growing quickly. The United States is the largest part of this market, with many pharmaceutical companies developing new medicines. These companies focus on creating safe and effective drug formulations to treat various health issues. Advances in technology and research are helping improve drug delivery methods. Canada is also contributing by supporting research and innovation in the healthcare sector. Additionally, strict regulations ensure high-quality standards for drug formulations. Overall, North America plays a crucial role in shaping the future of the drug formulation market.

Drug Formulation Market- Competitive Landscape:

The drug formulation market is competitive, with major players like Pfizer, Johnson & Johnson, and Roche leading the way. These companies invest heavily in research and development to create new and effective medications. Merck & Co. and Bristol-Myers Squibb are also significant competitors, focusing on innovative therapies. GSK and Novartis contribute with their strong product portfolios and global reach. Additionally, companies like AbbVie and Amgen are known for their specialty drugs. The market is constantly evolving, driven by advancements in technology and changing healthcare needs. This competition fosters innovation and helps bring better treatments to patients.

Recent Developments:

In September 2024, Sanofi, RadioMedix, and Orano Med announced a licensing agreement for a next-generation radioligand treatment aimed at rare cancers. This collaboration focuses on advancing innovative therapies for patients with these specific conditions.

In May 20224 Novartis has agreed to acquire Mariana Oncology, boosting its radioligand therapy pipeline. This strategic move enhances Novartis's capabilities in developing targeted cancer treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG FORMULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer
  • Johnson & Johnson
  • Roche
  • Merck & Co.
  • Bristol-Myers Squibb
  • GSK (GlaxoSmithKline)
  • Novartis
  • AbbVie
  • Sanofi
  • Amgen
  • AstraZeneca
  • Bayer
  • Teva Pharmaceutical Industries
  • Mylan
  • Celgene

GLOBAL DRUG FORMULATION MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Oral formulations
  • Tablets
  • Immediate Release
  • Modified Release
  • Chewable
  • Effervescent
  • Capsules
  • Hard Gelatine Capsules
  • Soft gel Capsules
  • Others
  • Powders & Granules
  • Lozenges & Pastilles
  • Gummies
  • Others
  • Parenteral formulations
  • Solutions
  • Suspensions
  • Emulsions for injection or infusion
  • Powders for injection or infusion
  • Gels for injection implants
  • Topical formulations
  • Pastes
  • Ointments and oils
  • Creams, lotions, and foams.
  • Gels, tinctures, and powders
  • Sprays and patches
  • Inhalation formulations
  • Pressurized Metered Dose Inhaler
  • Dry Powder Inhaler (DPI)
  • Nebulizer

GLOBAL DRUG FORMULATION MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Others

GLOBAL DRUG FORMULATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Big Pharma Companies
  • Small & Medium Size Pharma Companies
  • Biotech Companies

GLOBAL DRUG FORMULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Drug Formulation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Drug Formulation Market Snippet by Dosage Form
    • 2.1.2. Drug Formulation Market Snippet by Indication
    • 2.1.3. Drug Formulation Market Snippet by End User
    • 2.1.4. Drug Formulation Market Snippet by Country
    • 2.1.5. Drug Formulation Market Snippet by Region
  • 2.2. Competitive Insights

3. Drug Formulation Key Market Trends

  • 3.1. Drug Formulation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Drug Formulation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Drug Formulation Market Opportunities
  • 3.4. Drug Formulation Market Future Trends

4. Drug Formulation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Drug Formulation Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Drug Formulation Market Landscape

  • 6.1. Drug Formulation Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Drug Formulation Market - By Dosage Form

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 7.1.2. Oral formulations
      • 7.1.2.1. Tablets
      • 7.1.2.1.1. Immediate Release
      • 7.1.2.1.2. Modified Release
      • 7.1.2.1.3. Chewable
      • 7.1.2.1.4. Effervescent
      • 7.1.2.2. Capsules
      • 7.1.2.2.1. Hard Gelatine Capsules
      • 7.1.2.2.2. Soft gel Capsules
      • 7.1.2.2.3. Others
      • 7.1.2.3. Powders & Granules
      • 7.1.2.4. Lozenges & Pastilles
      • 7.1.2.5. Gummies
      • 7.1.2.6. Others
    • 7.1.3. Parenteral formulations
      • 7.1.3.1. Solutions
      • 7.1.3.2. Suspensions
      • 7.1.3.3. Emulsions for injection or infusion
      • 7.1.3.4. Powders for injection or infusion
      • 7.1.3.5. Gels for injection implants
    • 7.1.4. Topical formulations
      • 7.1.4.1. Pastes
      • 7.1.4.2. Ointments and oils
      • 7.1.4.3. Creams, lotions, and foams.
      • 7.1.4.4. Gels, tinctures, and powders
      • 7.1.4.5. Sprays and patches
    • 7.1.5. Inhalation formulations
      • 7.1.5.1. Pressurized Metered Dose Inhaler
      • 7.1.5.2. Dry Powder Inhaler (DPI)
      • 7.1.5.3. Nebulizer

8. Drug Formulation Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2. Infectious Diseases
    • 8.1.3. Cancer
    • 8.1.4. Cardiovascular Diseases
    • 8.1.5. Diabetes
    • 8.1.6. Respiratory Diseases
    • 8.1.7. Central Nervous System Disorders
    • 8.1.8. Others

9. Drug Formulation Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Big Pharma Companies
    • 9.1.3. Small & Medium Size Pharma Companies
    • 9.1.4. Biotech Companies

10. Drug Formulation Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Drug Formulation Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Drug Formulation Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Drug Formulation Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Drug Formulation Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Drug Formulation Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Drug Formulation Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer
    • 11.2.2. Johnson & Johnson
    • 11.2.3. Roche
    • 11.2.4. Merck & Co.
    • 11.2.5. Bristol-Myers Squibb
    • 11.2.6. GSK (GlaxoSmithKline)
    • 11.2.7. Novartis
    • 11.2.8. AbbVie
    • 11.2.9. Sanofi
    • 11.2.10. Amgen
    • 11.2.11. AstraZeneca
    • 11.2.12. Bayer
    • 11.2.13. Teva Pharmaceutical Industries
    • 11.2.14. Mylan
    • 11.2.15. Celgene

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us